E7050
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for E7050, covering 2014-02-14 to 2022-01-03. Get the full timeline:
Most recent: Clinical Trial Update: E7050 in Combination With Cetuximab Versus Cetuximab Alone in the Treatment of Platinum-Resistant Squamous Cell Carcinoma of the Head and Neck [Phase 1, Phase 2]